FDA Approves Mepolizumab for COPD

(MedPage Today) -- The FDA approved mepolizumab (Nucala) for adults with inadequately controlled chronic obstructive pulmonary disease (COPD), drugmaker GSK announced on Thursday.
Labeling for the interleukin-5 (IL-5) antagonist stipulates use...